×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Yahoo Finance
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed...
3 weeks ago
Ovid Therapeutics Inc. (NASDAQ:OVID) Receives $8.08 Average PT from Brokerages
MarketBeat
Shares of Ovid Therapeutics Inc. (NASDAQ:OVID - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six...
2 days ago
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
Takeda has completed two Phase 3 trials studying soticlestat as a treatment for Lennox-Gastaut syndrome and Dravet syndrome; topline data...
3 weeks ago
Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024
Seeking Alpha
Ovid Therapeutics results from the phase 3 Skyline study, using soticlestat for the treatment of patients with Dravet Syndrome,...
1 month ago
Ovid Therapeutics stock holds Outperform on trial progress By Investing.com
Investing.com
On Tuesday, Oppenheimer maintained its positive stance on Ovid Therapeutics Inc shares (NASDAQ:OVID), reiterating an Outperform rating and a...
3 weeks ago
Ovid Therapeutics Inc. (NASDAQ:OVID) Expected to Earn Q2 2024 Earnings of ($0.25) Per Share
Defense World
Read Ovid Therapeutics Inc. (NASDAQ:OVID) Expected to Earn Q2 2024 Earnings of ($0.25) Per Share at Defense World.
2 weeks ago
Ovid Therapeutics Inc (OVID) Reports Q3 2023 Financial Results
Yahoo Finance
OVID reported a net loss of $11.3 million, or basic and diluted net loss per share attributable to common stockholders of $0.16, for the third...
6 months ago
OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024
InvestorPlace
OVID stock results show that Ovid Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of...
3 weeks ago
Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
markets.businessinsider.com
The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or...
2 months ago
Scrip Awards Lifetime Achievement Winner Jeremy Levin Urges Pharma To Put Humanity First :: Scrip
Scrip
In accepting Scrip's Lifetime Achievement Award, Ovid Therapeutics' CEO called on pharma to show responsible leadership and live up to its...
6 months ago